OMEICOS Therapeutics GmbH;Board of Regents, The University of Texas System;Max-Delbrück-Centrum für Molekulare Medizin
发明人:
FISCHER, Robert,KONKEL, Anne,WESSER, Tim,WESTPHAL, Philipp,SCHUNK, Wolf-Hagen,WESTPHAL, Christina,FALCK, John Russel
申请号：
HK18105994.5
公开号：
HK1246771A
申请日:
2018.05.09
申请国别(地区):
HK
年份:
2018
代理人:
摘要：
The present invention relates to compounds according to general formula (I) which are metabolically robust analogues of bioactive lipid mediators derived from omega-3 polyunsaturated fatty acids (n-3 PUFAs). The present invention further relates to compositions containing one or more of these compounds and to the use of these compounds or compositions for the treatment or prevention of cardiovascular diseases.
